Pharsight

Evekeo Odt patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10130580 ARBOR PHARMS LLC Taste-masked pharmaceutical compositions
Apr, 2024

(6 months from now)

US10441554 ARBOR PHARMS LLC Oral amphetamine composition
Mar, 2037

(13 years from now)

US11160772 ARBOR PHARMS LLC Oral amphetamine composition
Mar, 2037

(13 years from now)

Evekeo Odt is owned by Arbor Pharms Llc.

Evekeo Odt contains Amphetamine Sulfate.

Evekeo Odt has a total of 3 drug patents out of which 0 drug patents have expired.

Evekeo Odt was authorised for market use on 30 January, 2019.

Evekeo Odt is available in tablet, orally disintegrating;oral dosage forms.

The generics of Evekeo Odt are possible to be released after 10 March, 2037.

Drugs and Companies using AMPHETAMINE SULFATE ingredient

Market Authorisation Date: 30 January, 2019

Treatment: NA

Dosage: TABLET, ORALLY DISINTEGRATING;ORAL

More Information on Dosage

EVEKEO ODT family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic